carvedilol has been researched along with Morbid Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, PA | 1 |
| Cristofoletti, R | 1 |
| Vozmediano, V | 1 |
| de Gaitani, CM | 1 |
| da Silva, RM | 1 |
| Kemp, R | 1 |
| Sankarankutty, AK | 1 |
| Salgado Junior, W | 1 |
| Santos, JSD | 1 |
| de Moraes, NV | 1 |
| Nabbi, R | 1 |
| Riess, ML | 1 |
| Woehlck, HJ | 1 |
2 other studies available for carvedilol and Morbid Obesity
| Article | Year |
|---|---|
Effect of Roux-En-Y Gastric Bypass in the Pharmacokinetics of (R)-Carvedilol and (S)-Carvedilol.
Topics: Carvedilol; Comorbidity; Gastric Bypass; Humans; Obesity; Obesity, Morbid | 2023 |
Angiotensin-receptor-blocker-induced refractory hypotension responds to methylene blue.
Topics: Aged; Angiotensin Receptor Antagonists; Carbazoles; Carvedilol; Citalopram; Crystalloid Solutions; D | 2012 |